William Allan Corp’s West Pharmaceutical WST Stock Holding History

William Allan Corp’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.39M	Buy	13,526 +363	+3%	+$90.3K	2.01%	21
2025 Q4	$3.62M	Sell	13,163 -659	-5%	-$180K	2.05%	20
2025 Q3	$3.63M	Sell	13,822 -457	-3%	-$111K	2.03%	22
2025 Q2	$3.12M	Buy	14,279 +3,556	+33%	+$760K	1.82%	24
2025 Q1	$2.4M	Buy	10,723 +3,340	+45%	+$921K	1.51%	28
2024 Q4	$2.42M	Buy	7,383 +383	+5%	+$121K	1.49%	28
2024 Q3	$1.11M	Buy	7,000 +3,705	+112%	+$1.13M	0.69%	38
2024 Q2	$1.08M	Buy	+3,295	New	+$1.16M	0.73%	36

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Allan Corp's WST Position: Q1 2026 in Review

William Allan Corp increased its West Pharmaceutical (WST) stake by 2.8% in Q1 2026, buying an estimated $90.3K and bringing the position to 13,526 shares worth $3.39M. The position accounts for 2.01% of the portfolio, ranked #21.

William Allan Corp first reported a position in WST in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.63M in Q3 2025. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

William Allan Corp held 13,526 shares of West Pharmaceutical worth $3.39M as of Q1 2026.
William Allan Corp bought 363 West Pharmaceutical shares in Q1 2026, an estimated $90.3K.
West Pharmaceutical made up 2.01% of William Allan Corp's portfolio in Q1 2026, its #21 holding.
William Allan Corp first reported a position in West Pharmaceutical in Q2 2024 and has held it in 8 quarters since.
William Allan Corp's West Pharmaceutical position peaked at $3.63M in Q3 2025.
754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on William Allan Corp's 13F filing for Q1 2026, filed 14 May 2026.